Dietary Protein Effects In Elderly Women: Musculoskeletal, Renal, Cardiovascular And Body Composition Endpoints
Funder
National Health and Medical Research Council
Funding Amount
$478,946.00
Summary
Fractures and falls of the elderly are major health problems in our community in terms of disability and cost. It is critical to the future health of our aging population to develop non-pharmaceutical interventions to maintain health into old age. Epidemiologic studies have shown that relatively high protein intake is associated with increased bone mineral mass and reduced incidence of osteoporotic fracture in elderly people. Low protein intakes can lead to loss of muscle mass. To date there hav ....Fractures and falls of the elderly are major health problems in our community in terms of disability and cost. It is critical to the future health of our aging population to develop non-pharmaceutical interventions to maintain health into old age. Epidemiologic studies have shown that relatively high protein intake is associated with increased bone mineral mass and reduced incidence of osteoporotic fracture in elderly people. Low protein intakes can lead to loss of muscle mass. To date there have been no randomised trials of sufficient duration to examine the effects of increased dietary protein intake on bone and muscle health of the elderly. The aim of this study is to examine the effectiveness of protein supplementation for the prevention of osteoporosis and muscle wasting in elderly women, and the safety of such an intervention through monitoring renal function and risk factors for cardiovascular disease. Two hundred and twenty women will be recruited to this study and be assigned to protein group or placebo group. Women in the protein group will received 250 ml high protein drink (containing 30 g protein) per day and women in the placebo group will receive placebo drink containing the same amount of energy, calcium but no additional protein. Bone structure, muscle mass, body composition, renal function and risk factors for cardiovascular disease will be monitored during the 2 year study period. The results of this randomised, controlled study will clarify the role of protein on bone mass and structure, muscle mass and body composition in the elderly. At the same time, the safety of such intervention on renal and cardiovascular endpoints will also be evaluated. It is envisaged that the results of this study if positive will translate into both immediately applicable intervention strategies that are relevant at a program and an individual level.Read moreRead less
Assessment Of Airway Smooth Muscle Hypertrophy In Asthma And Chronic Obstructive Pulmonary Disease (COPD)
Funder
National Health and Medical Research Council
Funding Amount
$298,055.00
Summary
Asthma and chronic obstructive pulmonary disease (COPD) are common in the Australian community. The cause of asthma is unknown and although COPD is most often due to smoking cigarettes it remains unknown why it develops only in some smokers and in some non-smokers. The pathology of asthma and COPD includes increased thickness of the airway smooth muscle layer. In asthma this is associated with relatively normal airway lumen size and intermittent, excessive airway narrowing whereas in COPD it is ....Asthma and chronic obstructive pulmonary disease (COPD) are common in the Australian community. The cause of asthma is unknown and although COPD is most often due to smoking cigarettes it remains unknown why it develops only in some smokers and in some non-smokers. The pathology of asthma and COPD includes increased thickness of the airway smooth muscle layer. In asthma this is associated with relatively normal airway lumen size and intermittent, excessive airway narrowing whereas in COPD it is associated with fixed narrowing of the airway lumens. The increased smooth muscle layer might result from more or bigger smooth muscle cells or from more connective tissue (matrix) between the muscle cells. This project aims to determine which of these 3 factors causes the increased thickness of the smooth muscle layer in asthma and COPD. We hypothesise that in asthma there are more muscle cells and more matrix, and that in COPD there is only more matrix. These differences would account for the different behaviour of the airways in asthma and COPD. Currently there is no useful or practical method to measure the amount of matrix in the airway wall, especially in the smooth muscle. This project will study the amount of matrix and muscle in very thin airway sections (< 1 m) from a large number of cases of asthma and COPD to allow, for the first time, accurate assessment of the fractions of matrix and muscle in the smooth muscle layer, since they barely overlap on these thin sections. The results of this study are important because they will: differentiate between mechanisms of increased thickness of the airway smooth muscle layer in asthma and COPD and therefore identify different prevention and treatment strategies; help to develop a method of monitoring airway remodeling in airway diseases that can be applied to bronchial biopsies.Read moreRead less
I am a physiologist investigating the molecular basis of normal function in skeletal muscle and the dysfunctions occurring in various muscle diseases and in fatigue. In addition, I investigate analogous dysfunction of calcium release and excitability occu
Establishing STARS As A Therapeutic Target To Reduce Muscle Wasting And Improve Muscle Function
Funder
National Health and Medical Research Council
Funding Amount
$446,189.00
Summary
Muscle wasting occurs rapidly with disuse after injuries occurring at work, during sport, with chronic disease and in road accidents. It is also a consequence of ageing. Muscle wasting and reduced muscle function places considerable financial strain on our health care system. We aim to use gene therapy and pharmacological interventions to increase the levels of a protein called STARS. We hypothesize that STARS will reduce disuse-induced muscle wasting, increase recovery and improve function.
Genetic Basis For Skeletal Muscle Formation And Regeneration In Development And Disease
Funder
National Health and Medical Research Council
Funding Amount
$876,005.00
Summary
How does muscle grow and repair after injury or disease? This basic question in the focus of the research in this fellowship. Specific cells are put aside during development to generate the growth and provide stem cells required for regeneration. Using the advantages of the zebrafish system I will record the action of different stem cell populations during growth and disease. I will define the genes required for stem cell action and utilize this knowledge to create new therapeutic pathways.